IASLC Spotlight: Global Policy and Partnerships Committee - ILCN.org (ILCN/WCLC) In a Q&A with ILCN, Dr. Gilberto de Lima Lopes, Committee Chair, details how the committee is working to address the most significant global challenges in lung cancer care.

New on #ILCN: IASLC Spotlight, Global Policy & Partnerships Committee!
Learn how global experts are shaping policies to improve lung cancer prevention, early detection, and access to care worldwide.
bit.ly/4jyCUhz

Results From the AENEAS2 Trial Point to a New Frontline Treatment Option for NSCLC - ILCN.org (ILCN/WCLC) Research team led by Dr. Shun Lu presents aumolertinib with chemotherapy as an additional first-line treatment option during the 2025 AACR Annual Meeting.

📰 New in #ILCN: Dr. Shun Lu presents new data on aumolertinib + chemotherapy as a first-line treatment option for #NSCLC.

🔗 More details here: bit.ly/3YXwNu6
#LCSM

Beamion LUNG-01 Trial Results Support Zongertinib’s Potential as a First-Line Therapy - ILCN.org (ILCN/WCLC) Dr. John V. Heymach says the latest findings suggest zongertinib may address an unmet need for patients with HER2-mutant NSCLC.

🆕 Dr. John V. Heymatch shares the latest Beamion LUNG-1 trial results at #AACR25.

🔗 Read the full recap now on #ILCN: bit.ly/3Ft5Asn

#LCSM